US FDA Approves Sanofi/MannKind Inhaled Insulin Product

February 3, 2015 7:15 AM

16 0

Sanofi and MannKind Corp have just announced that their jointly developed Afrezza (insulin human) Inhalation Powder—the first and only inhaled insulin on the market—is now available for prescription in the United States at retail pharmacies across the country.

The U.S. Food and Drug Administration has approved Afrezza for the control of high blood pressure in adults with either type 1 or type 2 diabetes.

Read more

To category page